IFNG and neoplasm: We previously showed that mice vaccinated with three doses of irradiated TC-1/cGM-CSF tumor cell-based vaccine exhibited stronger IFN-γ production, higher dendritic cell recruitment in draining lymph nodes, and an enhanced survival rate in a mouse model [16].